SBNO2 Inhibitors
SBNO2 inhibitors are a class of chemical compounds designed to target and modulate the activity of the Strawberry Notch Homolog 2 (SBNO2) protein. SBNO2, also known as CGI-121 or KIAA0922, is a relatively newly discovered protein that plays diverse roles in cellular processes, although its functions are not yet fully elucidated. Inhibitors of SBNO2 are developed to interact with this protein, disrupting its molecular interactions and cellular activities.
These inhibitors are typically small molecules or compounds designed to bind to SBNO2, interfering with its binding partners or affecting its regulatory functions within the cell. Research into SBNO2 inhibitors is an area of active investigation, aimed at unraveling the precise roles of SBNO2 in various cellular pathways. Although the exact functions of SBNO2 are still being explored, its inhibition can provide valuable insights into its involvement in signaling cascades, transcriptional regulation, or other cellular processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can affect the translation of proteins involved in cell cycle progression, potentially reducing SBNO2 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that could downregulate several signaling pathways, potentially resulting in decreased SBNO2 expression. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Binds to heat shock protein 90 (Hsp90) and could disrupt protein folding, potentially leading to decreased SBNO2 stability and expression. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Known to alter endosomal and lysosomal pH, which may affect protein trafficking and degradation, possibly decreasing SBNO2 levels. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor that may block c-Jun N-terminal kinase pathway, affecting transcription and potentially reducing SBNO2 expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that could downregulate inflammatory response-related gene expression, including potentially SBNO2. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
A selective inhibitor of histone acetyltransferase p300, which may alter histone acetylation and gene expression, possibly affecting SBNO2. | ||||||
Stat3 Inhibitor VI, S3I-201 | 501919-59-1 | sc-204304 | 10 mg | $151.00 | 104 | |
Inhibits STAT3 phosphorylation and dimerization, potentially influencing transcription and reducing SBNO2 expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A MEK inhibitor that may prevent the activation of MAPK/ERK, potentially leading to decreased expression of certain genes including SBNO2. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Inhibits the 26S proteasome leading to altered protein degradation, which could indirectly affect SBNO2 expression. | ||||||